EcoDrugPlus

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSATEG00000000099
Gene Symbol: RPTOR
1 Cross references
214 Possible Orthologues:

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSATEG00000011958
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSATEG00000008563
Gene Symbol: RARB
3 Cross references
394 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSATEG00000004437
Gene Symbol: LOC113171044
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma A

Ensembl ID : ENSATEG00000022679
Gene Symbol: RARGA
2 Cross references
383 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSATEG00000024688
Gene Symbol: LOC113153936
3 Cross references
367 Possible Orthologues:

Retinoid X Receptor, Alpha A

Ensembl ID : ENSATEG00000001877
Gene Symbol: RXRAA
2 Cross references
231 Possible Orthologues:

Retinoid X Receptor, Beta B

Ensembl ID : ENSATEG00000007788
Gene Symbol: RXRBB
3 Cross references
211 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSATEG00000022985
Gene Symbol: RPL10
3 Cross references
407 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSATEG00000020485
Gene Symbol: RPL10A
3 Cross references
380 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSATEG00000003155
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSATEG00000022706
Gene Symbol: RPL12
2 Cross references
489 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).